Bottom line
How much do IBB and SHPAX overlap?
24% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 34.1% of IBB's assets and 33.2% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
IBB holds far more positions (254 vs 29), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and SHPAX have in common
| Holding | % of IBB | % of SHPAX | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 3.36% | 3.36% |
| Gilead Sciences, Inc. | 7.52% | 3.94% | 3.94% |
| Amgen, Inc. | 7.50% | 5.04% | 5.04% |
| Regeneron Pharmaceuticals, Inc. | 5.70% | 3.93% | 3.93% |
| United Therapeutics Corp. | 1.82% | 6.17% | 1.82% |
| Incyte Corp. | 1.62% | 2.89% | 1.62% |
| Medpace Holdings, Inc. | 1.16% | 3.37% | 1.16% |
| Exelixis, Inc. | 1.07% | 4.55% | 1.07% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- Alnylam Pharmaceuticals, Inc. — 5.68%
- IQVIA Holdings, Inc. — 3.18%
- Argenx SE — 3.15%
- Insmed, Inc. — 2.95%
- Mettler-Toledo International, Inc. — 2.49%
- Natera, Inc. — 2.11%
- BeOne Medicines Ltd. — 2.11%
- Biogen, Inc. — 2.03%
- Waters Corp. — 1.77%
- Illumina, Inc. — 1.41%
- Genmab A/S — 1.38%
- Neurocrine Biosciences, Inc. — 1.34%
- Ionis Pharmaceuticals, Inc. — 1.03%
- BioMarin Pharmaceutical, Inc. — 1.02%
Only in SHPAX
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Johnson & Johnson — 3.91%
- National Healthcare Corp — 3.72%
- Merck & Company Inc — 3.63%
- Cigna Group (the) — 3.63%
- Intuitive Surgical Inc — 3.14%
- Bristol-myers Squibb Company — 3.07%
- Stryker Corp — 2.40%
- Medtronic Plc — 2.20%
- Eli Lilly & Company — 2.11%
Asset mix
| Asset type | IBB | SHPAX |
|---|---|---|
| Stocks | 99.8% | 99.0% |
| Cash & short-term funds | 13.4% | 1.6% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)
Country mix
| Country | IBB | SHPAX |
|---|---|---|
| US | 98.6% | 86.1% |
| IE | 0.5% | 8.4% |
| CH | 2.7% | 4.5% |
| NL | 4.3% | — |
| DK | 2.2% | 1.6% |
| GB | 1.0% | — |
| KY | 0.9% | — |
| DE | 0.7% | — |
Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)
Check another pair
FAQ
How much do IBB and SHPAX overlap?
What stocks do IBB and SHPAX have in common?
Should I own both IBB and SHPAX?
Which holds more stocks, IBB or SHPAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.